Welcome to the HCV Advocate’s
AASLD Conference coverage. In an effort
to best serve our readership, we will post all the important and interesting
abstracts about HCV from the conference.
While attending the conference, we will update any abstracts that we personally cover at the conference. The
updated abstracts will be marked with the date that they have been updated and
posted. The other abstracts posted to
the web site are HCV related abstracts posted to www.aasld.org
that we have not been able to report on or update.
To locate specific abstracts
for each topic below, click on the links.
Please click here to view our fact sheet on reading and understanding an
abstract.
Thank You,
Alan Franciscus
Editor-in-Chief
Hepatitis C
●
Clinical Trials: New treatments for hepatitis C that have been studied
in humans, and various drugs that are in phase I, II and
●
Diagnostic
Tools: Various tests to diagnose
and manage hepatitis C including various biochemical marker, imaging, liver
biopsy for grading/staging liver disease and HCV RNA (viral load) tests. (updated Nov 13,
2009)
●
Epidemiology
& Transmission Issues:
Studies that look at populations infected with hepatitis C as well as the
transmission risk factors.
●
HCV
Treatment: The current treatments for hepatitis C, including
outcomes, side effects and treatment of various HCV populations. (updated Nov 13, 2009)
●
Natural
History: HCV symptoms, disease progression and management. (updated Nov 13, 2009)